Record Details

Transcriptomics study between Di vs Re in AML patients after chemotherapy and allo-HCT transplantation

Harvard Dataverse (Africa Rice Center, Bioversity International, CCAFS, CIAT, IFPRI, IRRI and WorldFish)

View Archive Info
 
 
Field Value
 
Title Transcriptomics study between Di vs Re in AML patients after chemotherapy and allo-HCT transplantation
 
Identifier https://doi.org/10.7910/DVN/MREDXP
 
Creator Arambam, Nevidita
 
Publisher Harvard Dataverse
 
Description Transcriptomics study was carried out to analyse the difference in diagnosis and relapse of the treatment conditions, Allogenic-hematopoietic cell transplantation (allo-HCT) and Intensive Chemotherapy
 
Subject Medicine, Health and Life Sciences
 
Contributor Arambam, Nevidita